Israel Englander Tg Therapeutics, Inc. Put Options Transaction History

Millennium Management LLC

  • $175 Billion
  • Q1 2025

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2025

May 15, 2025
BUY
$27.67 - $42.99 $199,224 - $309,528
7,200 New
7,200 $283,000
Q1 2024

May 15, 2024
SELL
$13.02 - $21.3 $644,490 - $1.05 Million
-49,500 Reduced 45.21%
60,000 $912,000
Q4 2023

Feb 14, 2024
BUY
$6.68 - $18.81 $731,460 - $2.06 Million
109,500 New
109,500 $1.87 Million
Q4 2022

Feb 14, 2023
BUY
$5.01 - $11.83 $3.68 Million - $8.69 Million
734,200 New
734,200 $8.69 Million

Others Institutions Holding TGTX

# of Institutions
415
Shares Held
88.1M
Call Options Held
2.34M
Put Options Held
1.94M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.97B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email